Kev tshawb fawb tsis ntev los no qhia tias ib koob tshuaj Pfizer/BioNTech mRNA tshuaj tiv thaiv BNT162b 2 muab kev tiv thaiv tawm tsam tus tshiab variants ntawm icov neeg uas muaj tus kab mob ua ntej.
Qhov kev pab tiv thaiv kab mob loj heev tiv thaiv tus kab mob kis thoob qhov txhia chaw COVID-19 tam sim no tab tom pib. Tib lub sijhawm, muaj cov lus ceeb toom ntawm qhov tshwm sim tshiab variants ntawm kev txhawj xeeb of SARS-CoV-2 virus. Nrog rau cov teb chaws xws li UK tau ua tiav thawj koob tshuaj rau feem tseem ceeb ntawm cov pej xeem, cov lus nug feem ntau tau hais txog kev ua tau zoo ntawm ib koob tshuaj tiv thaiv COVID hauv kev muab kev tiv thaiv tsim nyog rau cov tshiab. txawv of SARS-CoV-2 virus.
Ib txoj kev tshawb fawb tsis ntev los no tau saib hauv qhov no rau Pfizer's tshuaj tiv thaiv mRNA. Cov kws tshawb fawb tau tshawb xyuas yog tias txhaj tshuaj tiv thaiv ib zaug muab kev tiv thaiv kab mob sib kis rau txawv.
Raws li kev soj ntsuam ntawm T thiab B cov lus teb ntawm tes tom qab txhaj tshuaj tiv thaiv thawj zaug nrog Pfizer / BioNTech mRNA tshuaj tiv thaiv BNT162b2 hauv cov neeg ua haujlwm saib xyuas kev noj qab haus huv, cov kws tshawb fawb pom tau tias cov neeg uas muaj kab mob ua ntej tau txhim kho T cell tiv thaiv kab mob, tshuaj tiv thaiv kab mob zais cia B cell teb rau cov kab mob loj thiab cov tshuaj tiv thaiv tsis zoo tiv thaiv B.1.1.7 thiab B.1.351. Ntawm qhov tod tes, hauv cov tib neeg uas tsis muaj tus kab mob ua ntej, ib koob tshuaj tiv thaiv tau pom tias txo lub cev tiv thaiv kab mob. txawv. B.1.1.7 thiab B.1.351 spike mutations.
***
Tau qhov twg los:
Reynolds C., Pade C., thiab al 2021. Ua ntej tus kab mob SARS-CoV-2 cawm B thiab T cell teb rau txawv tom qab thawj koob tshuaj tiv thaiv. Kev tshawb fawb. Luam tawm 30 Plaub Hlis 2021: eabh1282. DOI: https://doi.org/10.1126/science.abh1282